Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 75 | 3,096−2.3%/yr | −2.3%/yr | 3.41.1× | 3% | 3,640 in 2030+2.7%/yr |
| Decompression & minimally invasive spine | 72 | 2,880−6.9%/yr | −6.9%/yr | 3.21.0× | 7% | 3,140 in 2030+1.5%/yr |
| Cervical fusion & disc arthroplasty | 34 | 1,567−5.6%/yr | −5.6%/yr | 1.71.0× | 7% | 1,710 in 2030+1.4%/yr |
| Kyphoplasty & vertebroplasty | 9 | 1,369−5.8%/yr | −5.8%/yr | 1.60.9× | 22% | 1,270 in 2030−1.2%/yr |
| SI joint fusion | 7 | 300+10%/yr | +10%/yr | 0.30.9× | 67% | 370 in 2030+3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 343 | 64,759−1.7%/yr | −1.7%/yr | 71.20.6× | 53% | 79,900 in 2030+3.6%/yr |
| Skin substitutes & wound grafts | 65 | 14,399+9.3%/yr | +9.3%/yr | 9.70.9× | 74% | 20,000 in 2030+5.6%/yr |
| Bone graft & orthobiologics | 15 | 773−3.8%/yr | −3.8%/yr | 0.91.3× | 5% | 720 in 2030−1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 191 | 13,392−3%/yr | −3%/yr | 14.71.1× | 91% | 15,000 in 2030+1.9%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 20 | 1,195+14%/yr | +14%/yr | 1.30.9× | 62% | 2,360 in 2030+12%/yr |
| Spinal cord & DRG stimulation | 17 | 798−4.7%/yr | −4.7%/yr | 0.80.9× | 69% | 850 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 74 | 6,490−18%/yr | −18%/yr | 7.81.5× | 72% | 6,500 in 20300%/yr |
| Superficial venous ablation | 64 | 4,583−7.7%/yr | −7.7%/yr | 5.00.8× | 100% | 5,820 in 2030+4.1%/yr |
| Peripheral arterial intervention | 21 | 3,651−12%/yr | −12%/yr | 4.00.6× | 46% | 4,960 in 2030+5.3%/yr |
| Thrombectomy, IVC filters & venous stents | 9 | 1,269−2.2%/yr | −2.2%/yr | 1.50.9× | 9% | 1,580 in 2030+3.7%/yr |
| Carotid revascularization | 20 | 1,108−4.6%/yr | −4.6%/yr | 1.31.0× | 0% | 1,310 in 2030+2.8%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 405−5.4%/yr | −5.4%/yr | 0.51.0× | 0% | 450 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 62 | 5,304−4.6%/yr | −4.6%/yr | 6.61.1× | 1% | 5,880 in 2030+1.7%/yr |
| Cholecystectomy & appendectomy | 78 | 3,999−6.7%/yr | −6.7%/yr | 4.81.1× | 0% | 4,290 in 2030+1.2%/yr |
| Colorectal resection | 9 | 1,488−6.4%/yr | −6.4%/yr | 1.81.0× | 0% | 1,450 in 2030−0.4%/yr |
| Antireflux & hiatal hernia surgery | 14 | 800−3.2%/yr | −3.2%/yr | 0.91.2× | 0% | 1,030 in 2030+4.3%/yr |
| Breast reconstruction | 1 | 590−6.3%/yr | −6.3%/yr | 0.71.5× | 0% | 900 in 2030+7.4%/yr |
| Bariatric surgery | 0 | 137−22%/yr | −22%/yr | 0.20.8× | 0% | 120 in 2030−2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 60 | 5,270−5.6%/yr | −5.6%/yr | 6.11.2× | 42% | 4,930 in 2030−1.1%/yr |
| Kidney stone management | 109 | 4,711−1.3%/yr | −1.3%/yr | 5.51.1× | 17% | 5,540 in 2030+2.7%/yr |
| Incontinence, prolapse & sacral neuromodulation | 34 | 2,423−0.2%/yr | −0.2%/yr | 2.81.1× | 14% | 2,640 in 2030+1.4%/yr |
| Hysterectomy, hysteroscopy & ablation | 18 | 2,052−1%/yr | −1%/yr | 2.61.0× | 8% | 2,340 in 2030+2.2%/yr |
| Prostatectomy & nephrectomy | 20 | 1,026−0.3%/yr | −0.3%/yr | 1.31.1× | 0% | 1,080 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 44 | 4,459−4%/yr | −4%/yr | 5.21.0× | 88% | 4,620 in 2030+0.6%/yr |
| Sleep apnea & airway implants | 8 | 238+64%/yr | +64%/yr | 0.31.1× | 6% | 380 in 2030+8.2%/yr |
| Ear tubes & middle ear surgery | 1 | 213−7.5%/yr | −7.5%/yr | 0.20.7× | 28% | 250 in 2030+2.7%/yr |
| Cochlear implants | 4 | 121+12%/yr | +12%/yr | 0.10.8× | 0% | 230 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 103 | 5,906−2.9%/yr | −2.9%/yr | 7.31.1× | 17% | 6,640 in 2030+2%/yr |
| Tumor ablation | 2 | 335+1.7%/yr | +1.7%/yr | 0.41.3× | 0% | 260 in 2030−3.9%/yr |
| Tumor & fibroid embolization | 5 | 259−8.1%/yr | −8.1%/yr | 0.30.5× | 64% | 920 in 2030+23%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 210 | 27,583+22%/yr | +22%/yr | 31.31.1× | 99% | 50,800 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 88 | 4,562−3.7%/yr | −3.7%/yr | 5.51.0× | 0% | 5,000 in 2030+1.5%/yr |
| EP ablation | 65 | 3,401+5%/yr | +5%/yr | 3.30.9× | 0% | 7,490 in 2030+14%/yr |
| LAA occlusion & loop recorders | 70 | 2,787+8.8%/yr | +8.8%/yr | 2.80.8× | 7% | 5,510 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 147 | 6,267−8%/yr | −8%/yr | 5.81.0× | 0% | 7,490 in 2030+3%/yr |
| Structural heart (TAVR, TEER) | 72 | 1,794+2.7%/yr | +2.7%/yr | 1.71.1× | 0% | 2,890 in 2030+8.3%/yr |
| Mechanical circulatory support | 0 | 422−6.1%/yr | −6.1%/yr | 0.50.9× | 0% | 500 in 2030+3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 17 | 378+12%/yr | +12%/yr | 0.51.1× | 0% | 530 in 2030+5.8%/yr |
| Aneurysm & intracranial embolization | 8 | 323+8.8%/yr | +8.8%/yr | 0.40.8× | 0% | 940 in 2030+19%/yr |
| DBS & VNS | 3 | 211+0.2%/yr | +0.2%/yr | 0.20.7× | 0% | 230 in 2030+1.1%/yr |
| CSF shunts | 0 | 123−9.2%/yr | −9.2%/yr | 0.10.7× | 0% | 180 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 221 | 47,191−3.3%/yr | −3.3%/yr | 53.60.9× | 89% | 50,000 in 2030+1%/yr |
| Vitreoretinal surgery | 19 | 1,497−3.1%/yr | −3.1%/yr | 1.80.7× | 88% | 1,580 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 495 | 93,642−4.3%/yr | −4.3%/yr | 113.01.0× | 53% | 102,100 in 2030+1.5%/yr |
| Bronchoscopy & lung nodule | 43 | 2,875+5.7%/yr | +5.7%/yr | 3.41.0× | 0% | 5,590 in 2030+12%/yr |
| ERCP & endoscopic ultrasound | 39 | 1,940−4.2%/yr | −4.2%/yr | 2.30.7× | 0% | 2,330 in 2030+3.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.